{
  "disease_name": "Cystinuria",
  "orpha_code": "214",
  "drugs": [
    {
      "name": "L-ergothioneine",
      "substance_url": "/en/drug/substance/627494?name=214&mode=orpha&region=&status=all",
      "substance_id": "627494",
      "regulatory_url": "/en/drug/regulatory/627498?name=214&mode=orpha&region=",
      "regulatory_id": "627498",
      "orpha_substance_code": "ORPHA:214",
      "details": [
        "L-ergothioneine(Medicinal product                        - 21/06/2021)Disease(s) concernedORPHA:214 Cystinuria",
        "L-ergothioneine(Medicinal product                        - 21/06/2021)",
        "(Medicinal product                        - 21/06/2021)",
        "Disease(s) concernedORPHA:214 Cystinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/627494?name=214&mode=orpha&region=&status=all",
          "text": "L-ergothioneine",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/214",
          "text": "ORPHA:214 Cystinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/627498?name=214&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Tripotassium citrate monohydrate and potassium hydrogen carbonate",
      "substance_url": "/en/drug/substance/489774?name=214&mode=orpha&region=&status=all",
      "substance_id": "489774",
      "regulatory_url": "/en/drug/regulatory/588821?name=214&mode=orpha&region=",
      "regulatory_id": "588821",
      "orpha_substance_code": "ORPHA:214",
      "details": [
        "Tripotassium citrate monohydrate and potassium hydrogen carbonate(Medicinal product                        - 09/01/2020)Disease(s) concernedORPHA:214 Cystinuria",
        "Tripotassium citrate monohydrate and potassium hydrogen carbonate(Medicinal product                        - 09/01/2020)",
        "(Medicinal product                        - 09/01/2020)",
        "Disease(s) concernedORPHA:214 Cystinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/489774?name=214&mode=orpha&region=&status=all",
          "text": "Tripotassium citrate monohydrate and potassium hydrogen carbonate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/214",
          "text": "ORPHA:214 Cystinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/588821?name=214&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "L-cystine bis(N-methylpiperazide)",
      "substance_url": "/en/drug/substance/520905?name=214&mode=orpha&region=&status=all",
      "substance_id": "520905",
      "regulatory_url": "/en/drug/regulatory/520913?name=214&mode=orpha&region=",
      "regulatory_id": "520913",
      "orpha_substance_code": "ORPHA:214",
      "details": [
        "L-cystine bis(N-methylpiperazide)(Medicinal product                        - 27/06/2018)Disease(s) concernedORPHA:214 Cystinuria",
        "L-cystine bis(N-methylpiperazide)(Medicinal product                        - 27/06/2018)",
        "(Medicinal product                        - 27/06/2018)",
        "Disease(s) concernedORPHA:214 Cystinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/520905?name=214&mode=orpha&region=&status=all",
          "text": "L-cystine bis(N-methylpiperazide)",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/214",
          "text": "ORPHA:214 Cystinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/520913?name=214&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "THIOLA",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/131080?name=214&mode=orpha&region=",
      "regulatory_id": "131080",
      "orpha_substance_code": "ORPHA:214",
      "details": [
        "THIOLA(Tradename)Disease(s) concernedORPHA:214 Cystinuria",
        "THIOLA(Tradename)",
        "(Tradename)",
        "Disease(s) concernedORPHA:214 Cystinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/25072?name=214&mode=orpha&region=&status=all",
          "text": "THIOLA",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/214",
          "text": "ORPHA:214 Cystinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131080?name=214&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": null,
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Fixed-dose combination of potassium citrate and potassium bicarbonate",
      "substance_url": "/en/drug/substance/638983?name=214&mode=orpha&region=&status=all",
      "substance_id": "638983",
      "regulatory_url": "/en/drug/regulatory/665276?name=214&mode=orpha&region=",
      "regulatory_id": "665276",
      "orpha_substance_code": "ORPHA:214",
      "details": [
        "Fixed-dose combination of potassium citrate and potassium bicarbonate(Medicinal product                        - 21/03/2024)Disease(s) concernedORPHA:214 Cystinuria",
        "Fixed-dose combination of potassium citrate and potassium bicarbonate(Medicinal product                        - 21/03/2024)",
        "(Medicinal product                        - 21/03/2024)",
        "Disease(s) concernedORPHA:214 Cystinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/638983?name=214&mode=orpha&region=&status=all",
          "text": "Fixed-dose combination of potassium citrate and potassium bicarbonate",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/214",
          "text": "ORPHA:214 Cystinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/665276?name=214&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "L-ergothioneine",
      "substance_url": "/en/drug/substance/627494?name=214&mode=orpha&region=&status=all",
      "substance_id": "627494",
      "regulatory_url": "/en/drug/regulatory/639004?name=214&mode=orpha&region=",
      "regulatory_id": "639004",
      "orpha_substance_code": "ORPHA:214",
      "details": [
        "L-ergothioneine(Medicinal product                        - 28/12/2022)Disease(s) concernedORPHA:214 Cystinuria",
        "L-ergothioneine(Medicinal product                        - 28/12/2022)",
        "(Medicinal product                        - 28/12/2022)",
        "Disease(s) concernedORPHA:214 Cystinuria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/627494?name=214&mode=orpha&region=&status=all",
          "text": "L-ergothioneine",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/214",
          "text": "ORPHA:214 Cystinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/639004?name=214&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "3-{[2,3,5,6-tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid",
      "substance_url": "/en/drug/substance/444708?name=214&mode=orpha&region=&status=all",
      "substance_id": "444708",
      "regulatory_url": "/en/drug/regulatory/444712?name=214&mode=orpha&region=",
      "regulatory_id": "444712",
      "orpha_substance_code": "ORPHA:306648",
      "details": [
        "3-{[2,3,5,6-tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid(Medicinal product                        - 19/06/2015)Disease(s) concernedORPHA:892 Von Hippel-Lindau diseaseORPHA:730 Autosomal dominant polycystic kidney diseaseORPHA:34149 Autosomal dominant tubulointerstitial kidney diseaseORPHA:88924 Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosisORPHA:90061 Non-infectious posterior uveitisORPHA:93545 Renal or urinary tract malformationORPHA:93548 Glomerular diseaseORPHA:93587 Genetic cystic renal diseaseORPHA:93603 Rare renal tubular diseaseORPHA:306648 Non-infectious anterior uveitis",
        "3-{[2,3,5,6-tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid(Medicinal product                        - 19/06/2015)",
        "(Medicinal product                        - 19/06/2015)",
        "Disease(s) concernedORPHA:892 Von Hippel-Lindau diseaseORPHA:730 Autosomal dominant polycystic kidney diseaseORPHA:34149 Autosomal dominant tubulointerstitial kidney diseaseORPHA:88924 Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosisORPHA:90061 Non-infectious posterior uveitisORPHA:93545 Renal or urinary tract malformationORPHA:93548 Glomerular diseaseORPHA:93587 Genetic cystic renal diseaseORPHA:93603 Rare renal tubular diseaseORPHA:306648 Non-infectious anterior uveitis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/444708?name=214&mode=orpha&region=&status=all",
          "text": "3-{[2,3,5,6-tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/892",
          "text": "ORPHA:892 Von Hippel-Lindau disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/730",
          "text": "ORPHA:730 Autosomal dominant polycystic kidney disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/34149",
          "text": "ORPHA:34149 Autosomal dominant tubulointerstitial kidney disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/88924",
          "text": "ORPHA:88924 Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/90061",
          "text": "ORPHA:90061 Non-infectious posterior uveitis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/93545",
          "text": "ORPHA:93545 Renal or urinary tract malformation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/93548",
          "text": "ORPHA:93548 Glomerular disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/93587",
          "text": "ORPHA:93587 Genetic cystic renal disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/93603",
          "text": "ORPHA:93603 Rare renal tubular disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/306648",
          "text": "ORPHA:306648 Non-infectious anterior uveitis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/444712?name=214&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "ORPHA:730 Autosomal dominant polycystic kidney disease\n                                \n\n\n\n\n                                    ORPHA:34149 Autosomal dominant tubulointerstitial kidney disease\n                                \n\n\n\n\n                                    ORPHA:88924 Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis\n                                \n\n\n\n\n                                    ORPHA:90061 Non-infectious posterior uveitis\n                                \n\n\n\n\n                                    ORPHA:93545 Renal or urinary tract malformation\n                                \n\n\n\n\n                                    ORPHA:93548 Glomerular disease\n                                \n\n\n\n\n                                    ORPHA:93587 Genetic cystic renal disease\n                                \n\n\n\n\n                                    ORPHA:93603 Rare renal tubular disease\n                                \n\n\n\n\n                                    ORPHA:306648 Non-infectious anterior uveitis\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Burixafor",
      "substance_url": "/en/drug/substance/689505?name=214&mode=orpha&region=&status=all",
      "substance_id": "689505",
      "regulatory_url": "/en/drug/regulatory/689915?name=214&mode=orpha&region=",
      "regulatory_id": "689915",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Burixafor(Medicinal product                        - 22/10/2024)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Burixafor(Medicinal product                        - 22/10/2024)",
        "(Medicinal product                        - 22/10/2024)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689505?name=214&mode=orpha&region=&status=all",
          "text": "Burixafor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689915?name=214&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Treosulfan",
      "substance_url": "/en/drug/substance/90799?name=214&mode=orpha&region=&status=all",
      "substance_id": "90799",
      "regulatory_url": "/en/drug/regulatory/136690?name=214&mode=orpha&region=",
      "regulatory_id": "136690",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Treosulfan(Medicinal product                        - 08/04/2015)Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Treosulfan(Medicinal product                        - 08/04/2015)",
        "(Medicinal product                        - 08/04/2015)",
        "Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90799?name=214&mode=orpha&region=&status=all",
          "text": "Treosulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/213500",
          "text": "ORPHA:213500 Rare ovarian cancer",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136690?name=214&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "busulfan",
      "substance_url": "/en/drug/substance/46335?name=214&mode=orpha&region=&status=all",
      "substance_id": "46335",
      "regulatory_url": "/en/drug/regulatory/131973?name=214&mode=orpha&region=",
      "regulatory_id": "131973",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "busulfan(Medicinal product                        - 21/04/1994)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "busulfan(Medicinal product                        - 21/04/1994)",
        "(Medicinal product                        - 21/04/1994)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/46335?name=214&mode=orpha&region=&status=all",
          "text": "busulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131973?name=214&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:00:23.138937",
  "run_number": 1,
  "total_drugs_found": 10,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Cystinuria&orphaCode=214&name=214&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Cystinuria",
    "orphaCode": "214",
    "name": "214",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}